[DIV28SUPER] [GRAYMAIL] NIDA Neuroscience Update, November 16, 2012

NIH Substance Use, Abuse, and Addiction Functional Integration

Posted on November 16th, 2012 by Dr. Larry Tabak

Today, Dr. Collins announced the Trans-NIH Substance Use, Abuse, and Addiction Functional Integration that will enhance the NIH Institute and Center (IC) collaborations around this important scientific and public health topic.

 

The Functional Integration is a collaborative framework that will draw on the past two years of collaboration among the NIH ICs on substance use, abuse, and addiction-related research. Already, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA) have made significant progress at integrating their intramural research programs in substance use, abuse, and addiction, including the appointment of a single Clinical Director for NIAAA and NIDA and the establishment of a joint genetics Intramural Research Program and a common Optogenetics lab. Additionally, they have initiated joint NIAAA and NIDA Council meetings.  By pooling resources and expertise, the Functional Integration will identify cross-cutting areas of research and confront challenges faced by multiple Institutes and Centers.

Over the past two years, we have also engaged in a serious effort to identify new opportunities in substance use, abuse, and addiction research and public health needs that are not currently being pursued across NIH.  We received exceptional feedback from stakeholders through our Scientific Strategic Plan Request for Information, public web meeting, and additional stakeholder meetings. The resulting draft plan will be a starting point for the Functional Integration leadership.

The NIAAA and NIDA Councils and the NCAB will meet on December 13 to discuss the Functional Integration. This is an open meeting and we will post the details within the next few days.

 

For draft strategic plan see http://www.nih.gov/blog/feedback/substance-abuse/new-opportunities.pdf

 

-----------------

 

TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih.gov>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

The National Institute on Drug Abuse (NIDA)  at the National Institutes of Health is an agency of the United States Department of Health and Human Services 

 

[DIV28SUPER] WCALB 2013 in Winter Park, Colorado: Second Call

 

The Winter Conference on Animal Learning and Behavior 

(http://www.american.edu/cas/psychology/wcalb/index.cfm) will convene in Winter Park, Colorado 

from Saturday evening, February 2, with departure Wednesday morning , February 6, 2013.  There

are a few remaining openings.  

KEYNOTE ADDRESS

Behavioral Dependence

Patrick M. Beardsley

Virginia Commonwealth University

&

Jack Bergman

Harvard Medical School

 

Abstract-- Pharmacological state (or context) and history can direct the expression of learned behavior (e.g., state dependent learning, drug discrimination).  Additionally, abrupt drug abstinence can control the expression of learned behavior, a phenomenon that can be defined as behavioral dependence.  In this presentation, examples of behavioral dependence will be described and contrasted with physical dependence.  In addition, the potential ramifications of behavioral dependence, as well as the implications for regulatory control of drugs, will be considered.

 

 

FOCUS SESSION

 

Pharmacological History and the Control and Expression of Learning and Behavior

 

Several of our focus Sessions have been published as special journal issues, and this years' will likely be also.  There is still room for another prepared participant or so in the Focus Session .  The format will be up to 25-minute presentations with a "research seminar" type discussion among participants.  Let me (sweiss@american.edu) know if you would like to join that session.  

In addition to the Keynote Addresses and the Focus Session, there are sessions determined by the interests of current year participants.  Graduate students are invited to present with the endorsement of their adviser.  Registration, four nights accommodations in a first-class shared condominium on the main street of Winter Park, an opening buffet reception and dinner in a fine restaurant is only $365/person. 

Please contact me (sweiss@american.edu) if you would like more information. 

Hope to see you in Winter Park,

 

Stan Weiss, Convener

Winter Conference on Animal Learning & Behavior

Department of Psychology

American University

Washington, DC 20016

 

 

 

 

[DIV28SUPER] Preliminary Description of Functional Integration of NIH SUAA Research Available

There’s now a barebones description of what the functional integration means posted at the NIH Feedback website. 

 

Best,

-geoff

 

Geoffrey K. Mumford, Ph.D. | Associate Executive Director for Government Relations Science Directorate American Psychological Association 750 First Street NE, Washington, DC 20002-4242 Tel: 202.336.6067 |  Fax: 202.336.6063 email: gmumford@apa.org | www.apa.org
P Most people consider the environment before printing their email.

 

 

 

 

 

 

 

 

 

 

 

 

[DIV28SUPER] FW: STATEMENT BY NIH DIRECTOR DR. FRANCIS COLLINS ON THE FUTURE OF SUBSTANCE USE, ABUSE, AND ADDICTION-RELATED RESEARCH AT NIH

FYI, some unexpected news from NIH.

Best,
-geoff

-----Original Message-----
From: NIH news releases and news items [mailto:NIHPRESS@LIST.NIH.GOV] On Behalf Of NIH OLIB (NIH/OD)
Sent: Friday, November 16, 2012 12:04 PM
To: NIHPRESS@LIST.NIH.GOV
Subject: STATEMENT BY NIH DIRECTOR DR. FRANCIS COLLINS ON THE FUTURE OF SUBSTANCE USE, ABUSE, AND ADDICTION-RELATED RESEARCH AT NIH

U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH NIH News NIH Office of the Director (OD) <http://www.nih.gov/icd/od/> For Immediate Release: Friday, November 16, 2012

CONTACT: NIH Office of Communications, 301-496-5787, <e-mail: nihnmb@mail.nih.gov>

STATEMENT BY NIH DIRECTOR DR. FRANCIS COLLINS ON THE FUTURE OF SUBSTANCE USE, ABUSE, AND ADDICTION-RELATED RESEARCH AT NIH

Two years ago, the National Institutes of Health's Scientific Management Review Board (SMRB) issued a report recommending that NIH move to establish a new institute focused on substance use, abuse, and addiction-related research to optimize NIH research in these areas. Another option strongly considered by the SMRB was the functional integration of existing research resources, rather than creation of a new institute.

After rigorous review and extensive consultation with stakeholders, I have concluded that it is more appropriate for NIH to pursue functional integration, rather than major structural reorganization, to advance substance use, abuse, and addiction-related research.  To that end, the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) will retain their institutional identities, while strengthening their ongoing efforts to work more closely with each other and with related research programs at other institutes and centers.

NIH has made significant progress in the last two years, coordinating research on substance use, abuse, and addiction across its various institutes and centers. This progress has bolstered my confidence that NIH can achieve the SMRB recommendations without structural reorganization. Moreover, given budget uncertainties, NIH must focus on advancing the entire biomedical research enterprise. The time, energy, and resources required for a major structural reorganization are not warranted, especially given that functional integration promises to achieve equivalent scientific and public health objectives. NIH will begin implementing this functional approach immediately, and develop metrics to ensure that we reach our goals to more effectively conduct and support research in these areas so vital to our nation's health.

The Office of the Director, the central office at NIH, is responsible for setting policy for NIH, which includes 27 Institutes and Centers. This involves planning, managing, and coordinating the programs and activities of all NIH components. The Office of the Director also includes program offices which are responsible for stimulating specific areas of research throughout NIH. Additional information is available at <http://www.nih.gov/icd/od/>.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <http://www.nih.gov>.

NIH...Turning Discovery into Health -- Registered, U.S. Patent and Trademark Office

###

This NIH Director's Statement is available online at:
<http://www.nih.gov/about/director/11162012_statement_suaa.htm>.

To subscribe (or unsubscribe) from NIH News Release mailings, go to <http://service.govdelivery.com/service/subscribe.html?code=USNIH_1>.

If you subscribed via the NIH LISTSERV, go to <https://list.nih.gov/cgi-bin/wa.exe?A0=nihpress>.

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] Post-doctoral fellowship; Yale SCOR, Department of Psychiatry, Yale University School of Medicine

Post-doctoral fellowship, Yale Translational Center to Develop Gender-Sensitive Treatment for Tobacco Dependence (Yale SCOR); Department of Psychiatry, Yale University School of Medicine

 

The Yale Translational Center to Develop Gender-Sensitive Treatment for Tobacco Dependence (Yale SCOR) in the Department of Psychiatry at the Yale University School of Medicine invites applications for postdoctoral fellowships.

                                       

The Yale-SCOR (http://psychiatry.yale.edu/scor/index.aspx) funded by the Office of Research on Women's Health and the National Institute of Drug Abuse, brings together leading basic and clinical science experts to establish a program of research aimed at identifying novel therapeutics to address the critical health disparity faced by female smokers.

 

The fellow will have the opportunity to work in a rich interdisciplinary and transdisciplinary research environment and be supervised by leading researchers with expertise in pre-clinical, human laboratory, and clinical treatment research methodology; addictions with an emphasis on nicotine dependence; gender-based research; molecular biology; neuroimaging; behavioral pharmacology, and stress reactivity. Postdoctoral fellows will participate in a diverse training program including both didactic seminars (e.g., grant and scientific writing skills, career development, and biostatistics) and individualized mentoring to build personalized programs of research. The successful candidate will be expected to contribute to, and develop research expertise through, the pursuit of defined research projects relevant sex/gender differences in tobacco. The position will be supported through an NIH training mechanism.

 

Applicants must have completed an MD or Ph.D. or equivalent degree in psychology, public health, pharmacology, neuroscience, or a related discipline. An interest in and experience with nicotine dependence and/or gender-based research is relevant, but not necessary for acceptance.

 

Interested applicants should send a letter of interest, curriculum vitae, and the names of three references to: Dr. Sherry McKee; Director, Yale-SCOR; Department of Psychiatry, Yale University School of Medicine; 2 Church St. South, Suite 109; New Haven, CT 06519 or sherry.mckee@yale.edu.

 

US Citizenship or Permanent Residency is required and successful applicants will be required to undergo a criminal background check.

 

Yale University School of Medicine is an Affirmative Action/Equal Opportunity Employer

 

[DIV28SUPER] APA 2013 proposal deadline extended to 11/20/12

Attention Division 28 members:

 

The deadline for Division proposals and film/media proposals has been extended to Tuesday, Nov. 20, 2012, 11:59pm EST to accommodate individuals affected by Hurricane Sandy.

 

 

Thanks,

 

Katie Saulsgiver

 

 

Kathryn Saulsgiver, Ph.D.

Division 28 Program Chair

Center for Health Incentives and Behavioral Economics

University of Pennsylvania

730 Blockley Hall

423 Guardian Drive

Philadelphia, PA 19104-6021

email: kasau@mail.med.upenn.edu

phone: 215.746.4923

fax: 215-573-4132

 

 

[DIV28_ANNOUNCEMENT] Division 28 Newsletter and REMINDER of 11/16/2012 Convention Submission Deadline!

Please see the attached Division 28 newsletter. Also, please remember
that the deadline for division proposals is November 16th, 2012.

Division 28 will be accepting submissions for symposia, posters, and papers (may be accepted as posters). Translational proposals on therapeutic utility of behavioral economics are encouraged. An award will be given to one predoctoral student poster. For more information or to submit a proposal please visit http://apacustomout.apa.org/ConvCall.

For questions regarding the call for proposals or to recommend a topic please contact Kathryn A. Saulsgiver, PhD kasau@mail.med.upenn.edu.

Deadline for Division Proposals:  Friday, November 16, 2012

--
Kelly Dunn, Ph.D.
Instructor
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________div28announce____________________________
A Division 28 announcement-only list twitter: @apadiv28 join our network